Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100046624Phase 4Recruiting
Phase 4, randomised trial of remimazolam in bronchopulmonary diseases (3 arms), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoints: Heart rate, Noninvasive blood pressure and 5 more. Started Aug 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100046624.